<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00977340</url>
  </required_header>
  <id_info>
    <org_study_id>StudieAlptraum1</org_study_id>
    <nct_id>NCT00977340</nct_id>
  </id_info>
  <brief_title>Study on the Psychotherapeutic Treatment of Chronic Nightmares</brief_title>
  <official_title>Psychotherapeutic Treatment of Chronic Nightmares: Differential Efficacy of Imagery Rehearsal Therapy Compared to Confrontation and Psychotherapeutic Placebo</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Goethe University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Goethe University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether a change in the content of nightmares is
      necessary at all in the treatment of chronic nightmares or if a single confrontation with
      their content is sufficient to reduce nightmare frequency significantly.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The inclusion and exclusion criteria are assessed during a telephone interview. If the
      participants meet the criteria, they are randomly assigned to two intervention groups or an
      active control group. In the first session the participants who suffer from chronic
      nightmares are interviewed using the Structured Clinical Interview for DSM-IV (SCID-I and
      -II) to determine the clinical diagnosis; in addition, they are given questionnaires and
      record sheets to obtain baseline data. They are asked to record their nightmares in a &quot;dream
      diary&quot; up until the next session four weeks later. At that session they learn one of three
      interventions to reduce nightmares. The first group receives imagery rehearsal treatment in
      which participants learn to consciously alter the contents of their nightmares and then to
      visualize the new set of images. The second group is subjected to confrontation treatment in
      which they are instructed to confront their nightmares until habituation. The third group,
      the psychotherapeutic placebo group, just learn an imagination technique, without reference
      to their nightmares. At the end of the intervention session all participants receive written
      instructions on how to perform the learned method at home. They must also record their dreams
      up until the next session. That session and the last one are used for data acquisition. At
      these sessions, the participants are asked to fill in the questionnaires given to them at the
      beginning of the treatment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>frequency of nightmares</measure>
    <time_frame>in the first diagnostical session, four weeks after interventional session in addition to follow-up-measurement</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>in the first diagnostical session, four weeks after interventional session in addition to follow-up-measurement</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>in the first diagnostical session, four weeks after interventional session in addition to follow-up-measurement</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sleep quality (LISST-Landecker Survey of Sleep Quality)</measure>
    <time_frame>in the first diagnostical session, four weeks after interventional session in addition to follow-up-measurement</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>self efficacy (General self efficacy, Jerusalem &amp; Schwarzer)</measure>
    <time_frame>in the first diagnostical session, four weeks after interventional session in addition to follow-up-measurement</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>nightmare effect survey (Krakow)</measure>
    <time_frame>in the first diagnostical session, four weeks after interventional session in addition to follow-up-measurement</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>nightmare distress questionnaire (Belicki)</measure>
    <time_frame>in the first diagnostical session, four weeks after interventional session in addition to follow-up-measurement</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Nightmare Disorder</condition>
  <arm_group>
    <arm_group_label>Imagery Rehearsal Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Imagery Rehearsal Treatment; 1 session on-site and 4 weeks of individual daily training; following principles Krakow and Zadra (2006)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Confrontation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Confrontation with nightmare content, until fear reaction habituates; 1 session on-site and 4 weeks of individual daily training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Imagination</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Imagination of a safe and pleasant site; 1 session on-site and 4 weeks of individual daily training</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Imagery Rehearsal Treatment</intervention_name>
    <description>Imagery Rehearsal Therapy</description>
    <arm_group_label>Imagery Rehearsal Treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>confrontation</intervention_name>
    <description>Confrontation</description>
    <arm_group_label>Confrontation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>imagination</intervention_name>
    <description>Imagination</description>
    <arm_group_label>Imagination</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  nightmare frequency of at least one night per week for six month duration

          -  stable medication

          -  if currently in psychotherapy: no treatment of nightmares

          -  Informed consent

        Exclusion Criteria:

          -  Life time clinical diagnosis of schizophrenia, schizoaffective disorder or bipolar
             disorder according to DSM-IV

          -  Body mass index &lt; 17

          -  Initiation of nightmares after taking pharmaceuticals

          -  Clinical diagnosis of alcohol or drug addiction according to DSM-IV

          -  Mental retardation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Regina Steil, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johann Wolfgang Goethe University - Department of Clinical Psychology and Ppsychotherapy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Regina Steil, PhD</last_name>
    <phone>+49 69/798 23379</phone>
    <email>steil@psych.uni-frankfurt.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ulrich Stangier, Prof.</last_name>
    <phone>+49 151/177 542 01</phone>
    <email>stangier@psych.uni-frankfurt.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Johann Wolfgang Goethe University - Department of Clinical Psychology and Ppsychotherapy</name>
      <address>
        <city>Frankfurt/Main</city>
        <state>Hessen</state>
        <zip>D-60054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Regina Steil, PhD</last_name>
      <phone>+49 69/798 23379</phone>
    </contact>
    <contact_backup>
      <last_name>Ulrich Stangier, Prof.</last_name>
      <phone>+49 151/177 542 01</phone>
    </contact_backup>
    <investigator>
      <last_name>Regina Steil, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johann Wolfgang Goethe University - Department of Clinical Psychology and Ppsychotherapy</name>
      <address>
        <city>Frankfurt/Main</city>
        <state>Hessen</state>
        <zip>D-60054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Regina Steil, PhD</last_name>
      <phone>+49 69/798 23379</phone>
    </contact>
    <contact_backup>
      <last_name>Ulrich Stangier, Prof.</last_name>
      <phone>+49 151/177 542 01</phone>
    </contact_backup>
    <investigator>
      <last_name>Regina Steil, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2009</study_first_submitted>
  <study_first_submitted_qc>September 14, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2009</study_first_posted>
  <last_update_submitted>April 27, 2016</last_update_submitted>
  <last_update_submitted_qc>April 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Goethe University</investigator_affiliation>
    <investigator_full_name>Regina Steil</investigator_full_name>
    <investigator_title>Scientific director behavior therapy outpatient center</investigator_title>
  </responsible_party>
  <keyword>Chronic nightmare sufferers</keyword>
  <keyword>nightmares</keyword>
  <keyword>Imagery Rehearsal Therapy IRT</keyword>
  <keyword>sleep disturbance</keyword>
  <keyword>treatment of nightmares</keyword>
  <keyword>confrontation</keyword>
  <keyword>People who suffer of chronic nightmares</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychotropic Drugs</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

